Beta-Lactam vs. Fluoroquinolone Monotherapy for <i>Pseudomonas aeruginosa</i> Infection: A Systematic Review and Meta-Analysis

Beta-Lactam vs. Fluoroquinolone Monotherapy for <i>Pseudomonas aeruginosa</i> Infection: A Systematic Review and Meta-Analysis

Introduction: <i>Pseudomonas aeruginosa</i> (PA) is a leading cause of healthcare-associated infections. A variety of antibiotic classes are used in the treatment of PA infections, including beta-lactams (BLs) and fluoroquinolones (FQs), given either together in combination therapy or al...

Full description

Bibliographic Details
Main Authors:	Eric Reid, Ryan W. Walters, Christopher J. Destache
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Antibiotics
Subjects:	fluoroquinolone beta-lactam <i>Pseudomonas aeruginosa</i> infection systematic review
Online Access:	https://www.mdpi.com/2079-6382/10/12/1483

Similar Items

High prevalence of <i>bla<sub>VEB</sub></i>, <i>bla<sub>GES</sub></i> and <i>bla<sub>PER</sub></i> genes in beta-lactam resistant clinical isolates of <i>Pseudomonas aeruginosa</i>
by: Saboura Haghighi, et al.
Published: (2022-04-01)

Effectiveness of empiric aztreonam compared to other beta-lactams for treatment of Pseudomonas aeruginosa infections
by: Hogan M, et al.
Published: (2018-10-01)

Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa
by: Lei Zhao, et al.
Published: (2020-08-01)

In Vitro Comparison of Antibacterial and Antibiofilm Activities of Selected Fluoroquinolones against <i>Pseudomonas aeruginosa</i> and Methicillin-Resistant <i>Staphylococcus aureus</i>
by: Majed M. Masadeh, et al.
Published: (2019-01-01)

Relation between Resistance to Antipseudomonal β-Lactams and ampC and mexC Genes of Pseudomonas aeruginosa
by: Fatemeh Rezaei, et al.
Published: (2016-01-01)

Penetration through Outer Membrane and Efflux Potential in <i>Pseudomonas aeruginosa</i> of Bulgecin A as an Adjuvant to β-Lactam Antibiotics
by: Choon Kim, et al.
Published: (2023-02-01)

Pseudomonas aeruginosa, Staphylococcus aureus, and Fluoroquinolone Use
by: Conan MacDougall, et al.
Published: (2005-08-01)

Stability Studies of Antipseudomonal Beta Lactam Agents for Outpatient Therapy
by: Beatriz Fernández-Rubio, et al.
Published: (2023-11-01)

Incidence of metallo-beta-lactamase-producing <i> Pseudomonas aeruginosa</i> in diabetes and cancer patients
by: Varaiya Ami, et al.
Published: (2008-04-01)

Antimicrobial Susceptibility Testing in <i>Pseudomonas aeruginosa</i> Biofilms: One Step Closer to a Standardized Method
by: Carmen Lozano, et al.
Published: (2020-12-01)

The Prevalence of Fluoroquinolone Resistant Genes in Clinical Isolates of Pseudomonas Aeruginosa of Plasmid Origin Isolated From Patients Admitted to Alzahra Hospital of Isfahan
by: Behrooz Ataei, et al.
Published: (2022-04-01)

The plethora of resistance mechanisms in Pseudomonas aeruginosa: transcriptome analysis reveals a potential role of lipopolysaccharide pathway proteins to novel β-lactam/β-lactamase inhibitor combinations
by: Mariana Castanheira, et al.
Published: (2022-12-01)

Delafloxacin––A novel fluoroquinolone for the treatment of ciprofloxacin‐resistant Pseudomonas aeruginosa in patients with cystic fibrosis
by: Beverley Cherie Millar, et al.
Published: (2021-01-01)

Respiratory Fluoroquinolones Monotherapy vs. β-Lactams With or Without Macrolides for Hospitalized Community-Acquired Pneumonia Patients: A Meta-Analysis
by: Sitong Liu, et al.
Published: (2019-05-01)

Fitness Cost of Fluoroquinolone Resistance in Clinical Isolates of Pseudomonas aeruginosa Differs by Type III Secretion Genotype
by: Melissa Agnello, et al.
Published: (2016-10-01)

Design and Synthesis of Lactams Derived from Mucochloric and Mucobromic Acids as Pseudomonas aeruginosa Quorum Sensing Inhibitors
by: Basmah Almohaywi, et al.
Published: (2018-05-01)

The Efficacy of Using Combination Therapy against Multi-Drug and Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> in Clinical Settings
by: Frank Jones, et al.
Published: (2022-02-01)

Activity of Delafloxacin and Comparator Fluoroquinolones against Multidrug-Resistant <i>Pseudomonas aeruginosa</i> in an In Vitro Cystic Fibrosis Sputum Model
by: Vaughn D. Craddock, et al.
Published: (2023-06-01)

In vitro activity of antimicrobial combinations against multidrug-resistant Pseudomonas aeruginosa
by: Denissani Aparecida Ferrari dos Santos Lima, et al.
Published: (2013-06-01)

Murepavadin induces envelope stress response and enhances the killing efficacies of β-lactam antibiotics by impairing the outer membrane integrity of Pseudomonas aeruginosa
by: Xiaoya Wei, et al.
Published: (2023-10-01)

Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> Strains-Distribution of the Essential Enzymatic Virulence Factors Genes
by: Tomasz Bogiel, et al.
Published: (2020-12-01)

Resistance in <i>Pseudomonas aeruginosa</i>: A Narrative Review of Antibiogram Interpretation and Emerging Treatments
by: Federico Giovagnorio, et al.
Published: (2023-11-01)

Mutations of gyrA and parC Genes in Ciprofloxacin-Resistance Isolates of Pseudomonas Aeruginosa from Burn Wounds in Yazd City, Iran
by: Sahar Sadat Emadi, et al.
Published: (2017-06-01)

Clinical Relevance of Antibiotic Susceptibility Profiles for Screening Gram-negative Microorganisms Resistant to Beta-Lactam Antibiotics
by: Francisco Montiel-Riquelme, et al.
Published: (2020-10-01)

<i>Pseudomonas aeruginosa</i> Biofilms
by: Minh Tam Tran Thi, et al.
Published: (2020-11-01)

Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
by: Sarah Grace Gunter, et al.
Published: (2020-06-01)

Identification of Beta-Lactamase-Producing Pseudomonas aeruginosa with Multiple Antibiotic Resistances
by: Hossein Fazzeli, et al.
Published: (2012-03-01)

Current Prevalence of the crpP Gene in Carbapenemase-Producing Pseudomonas aeruginosa Blood Isolates in Korea
by: Jinho Heo, et al.
Published: (2022-06-01)

Enhancing activity of β-lactam and fluoroquinolones antibiotics by artemisinin and its derivatives against MDR Escherichia coli
by: Shahbaz Ul Haq, et al.
Published: (2022-11-01)

Determining the Prevalence of qnrB Gene in Pseudomonas Aeruginosa Strains Isolated from Clinical Centers in Tehran in 1394
by: Mitra Salehi, et al.
Published: (2018-08-01)

Beta-Lactam-Resistant <i>Enterobacterales</i> Isolated from Landfill Leachates
by: Alejandra Mondragón-Quiguanas, et al.
Published: (2022-09-01)

Mutations in gyrB play an important role in ciprofloxacin-resistant Pseudomonas aeruginosa
by: Feng X, et al.
Published: (2019-02-01)

Pharmacokinetic Drug Interactions of Antimicrobial Drugs: A Systematic Review on Oxazolidinones, Rifamycines, Macrolides, Fluoroquinolones, and Beta-Lactams
by: Jan-Willem C. Alffenaar, et al.
Published: (2011-11-01)

Transcending the challenge of evolving resistance mechanisms in Pseudomonas aeruginosa through β-lactam-enhancer-mechanism-based cefepime/zidebactam
by: Andrea M. Hujer, et al.
Published: (2023-12-01)

Silk-Based Therapeutics Targeting <i>Pseudomonas aeruginosa</i>
by: Tina B. McKay, et al.
Published: (2019-09-01)

The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial
by: A. Abdulla, et al.
Published: (2020-01-01)

Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam
by: Nguyen KV, et al.
Published: (2018-02-01)

Prevalence of the Genes Associated with Biofilm and Toxins Synthesis amongst the <i>Pseudomonas aeruginosa</i> Clinical Strains
by: Tomasz Bogiel, et al.
Published: (2021-02-01)

Bacteriophage–Antibiotic Combination Therapy against <i>Pseudomonas aeruginosa</i>
by: Guillermo Santamaría-Corral, et al.
Published: (2023-06-01)

The Impact of the Virulence of <i>Pseudomonas aeruginosa</i> Isolated from Dogs
by: Telma de Sousa, et al.
Published: (2023-05-01)